Concepedia

Author

Lisa Geiselhart

Science Applications International Corporation (United States)

Also Known As

L Geiselhart, L. Geiselhart, L.A. Geiselhart, Lisa A Geiselhart, Lisa A. Geiselhart, Lisa Geiselhart

16

Publications

470

Citations

6

H-Index

17

Concepts

All Affiliations

Science Applications International Corporation (United States)National Cancer InstituteFrederick National Laboratory for Cancer ResearchAlbany Medical Center HospitalCenter for Cancer Research
LG

About

Lisa Geiselhart is an author at Science Applications International Corporation (United States) specializing in immunology, immunotherapy, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

189

2

Immunology

3

3

189

3

Cell Biology

1

1

109

4

Pharmacology

1

1

28

5

Autoimmunity

1

1

28

Lisa Geiselhart

×

5

Publications

454

Citations

5

H-Index

YearCitations

IL-7 Administration Alters the CD4:CD8 Ratio, Increases T Cell Numbers, and Increases T Cell Function in the Absence of Activation

Lisa Geiselhart, Courtney A. Humphries, T A Gregorio,

The Journal of Immunology

2001

139

IFN-γ and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy

Jon M. Wigginton, Eilene Gruys, Lisa Geiselhart,

Journal of Clinical Investigation

2001

126

IFN-γ and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy

Jon M. Wigginton, Eilene Gruys, Lisa Geiselhart,

Journal of Clinical Investigation

2001

109

Inhibition of Human T Lymphoblast Proliferation by Hydroquinone

Qing Li, Lisa Geiselhart, James N. Mittler,

Toxicology and Applied Pharmacology

1996

52

The Cigarette Tar Componentp-Benzoquinone Blocks T-Lymphocyte Activation by Inhibiting Interleukin-2 Production, but Not CD25, ICAM-1, or LFA-1 Expression

Lisa Geiselhart, Todd Christian, Fred L. Minnear,

Toxicology and Applied Pharmacology

1997

28

Page 1